Intelivation

Intelivation

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Intelivation Technologies is a private, commercial-stage medical device company founded in 2018 and headquartered in San Francisco. It operates as an innovation hub, developing a broad portfolio of orthopedic and spinal implants, including its Advantage C cervical cage, Golden Isles pedicle screw system, and Inlet series of extremity plating systems. The company appears to be in a revenue-generating, commercial phase, selling its FDA-cleared products directly to the healthcare market with a focus on quality and disruptive innovation in a highly competitive sector.

OrthopedicsNeurosurgery

Technology Platform

Focus on design and materials engineering of traditional orthopedic implants, utilizing biomaterials (PEEK, Titanium alloys) and incorporating 3D printing/additive manufacturing for specific devices. No evident AI/ML or digital health platform from public materials.

Opportunities

The large and growing global market for spinal and extremity implants, driven by demographic trends, presents a significant addressable opportunity.
The company's focus on surgeon-centric design and integration of 3D printing could allow it to capture share in specific niches by offering differentiated ease-of-use and potentially better patient outcomes.

Risk Factors

Intense competition from well-established, resource-rich medical device giants poses a major commercial threat.
The company also faces inherent regulatory, supply chain, and reimbursement risks common to the medtech sector, and its current product portfolio does not reflect the disruptive AI/ML technology suggested by its listed sectors.

Competitive Landscape

Intelivation competes in the highly consolidated orthopedic implant market against dominant players like Medtronic, Stryker, Johnson & Johnson, and Zimmer Biomet, as well as numerous smaller specialized companies. Its competition is based on implant design, surgeon relationships, price, and service, rather than on a novel technology platform.